AI Terminal
Fresenius Medical Care AG & Co. KGaA
Transaction in Own Shares • Nov 11, 2019
165_rns_2019-11-11_e347260c-6dd4-43c4-a4ad-449909f0ef4a.html
Transaction in Own Shares
Open in ViewerOpens in native device viewer
News Details
Other Capital Market Information | 11 November 2019 09:44
Fresenius Medical Care AG & Co. KGaA: Release of a capital market information
Fresenius Medical Care AG & Co. KGaA / Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052
11.11.2019 / 09:44
Dissemination of a Post-admission Duties announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
– Share buy-back – 21 st Interim Report
In the period from November 4, 2019 until and including November 8, 2019, a total of 177,000 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA (‘Fresenius Medical Care’) announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.
The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange:
| Day of repurchase | Aggregated volume in number of shares | Weighted average share price in EUR |
| 04.11.2019 | 36,000 | 66.5550 |
| 05.11.2019 | 36,000 | 67.7284 |
| 06.11.2019 | 35,000 | 67.7370 |
| 07.11.2019 | 35,000 | 68.6833 |
| 08.11.2019 | 35,000 | 68.6178 |
The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including November 8, 2019 therefore amounts to 3,903,735 shares.
Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care’s website at www.freseniusmedicalcare.com under section Investors.
Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board
Bad Homburg v.d.H., November 11, 2019
11.11.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Fresenius Medical Care AG & Co. KGaA |
| Else-Kröner-Straße 1 | |
| 61352 Bad Homburg | |
| Germany | |
| Internet: | www.freseniusmedicalcare.com |
| End of News | DGAP News Service |